← Back to Clinical Trials
Recruiting NCT04837105

NCT04837105 Serious Game-based Intervention in Gait Rehabilitation for Children With Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04837105
Status Recruiting
Phase
Sponsor Fondation Ellen Poidatz
Condition Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 14 participants
Start Date 2021-04-15
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Serious game ARROW CPTreadmill

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 14 participants in total. It began in 2021-04-15 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Cerebral palsy (CP) is defined as a group of movement and posture disorders that cause activity limitation due to brain damage during fetal development or in the first year of life. Motor activities, and in particular walking, can be affected by many factors including sensory deficits, biomechanical and postural limitations, muscle weakness and spasticity. Theories of gait training guide rehabilitation management strategies. Among these, intensification, variability and specific training of walking parameters (speed, step length, cadence) have shown their effectiveness. Delivering sensory feedback during gait rehabilitation exercises is a complementary approach to improve motor learning during rehabilitation. On the other hand, motivation is a key factor in the success of rehabilitation. The addition of walking exercises performed through a serious game in augmented reality (AR) appears relevant for the rehabilitation of children with CP after surgery. The serious game ARRoW-CP is based on the latest advances in the literature in terms of gait rehabilitation protocol but also on the results of a clinical study conducted by our team, to identify the best feedback modalities to be delivered during the serious rehabilitation game.

Eligibility Criteria

Inclusion Criteria: * A clinical diagnosis of CP mentioned in the medical record * Minor child for the entire duration of the protocol, i.e. between 10 and 17 years of age (the child must be less than 18 years of age at the time of the last check-up scheduled 1 year after inclusion in the study) * Global Motor Function Classification System (GMFCS) levels I to III * Functional Mobility Scale 50 meters rating superior or equal to 2 (ability to walk on 50m using a walker or frame without help from another person) * Ability to cooperate, understand and follow simple instructions to play. * Patient affiliated to the French social security system * Voluntary patient whose parents have given their consent for their child to participate in the study * Patient who has undergone multisite surgery of the lower limbs including bone procedures at least 7 weeks before the start of the procedure Exclusion Criteria: * A diagnosis of photosensitive epilepsy mentioned in the medical file AND/OR a mention in the child's medical file or by the parents or by the child of a history of epileptic seizures occurring during the practice of a video game * A visual, cognitive or auditory impairment at a level that would interfere with playing the game. The patient must have normal or corrected vision and hearing.

Frequently Asked Questions

Who can join the NCT04837105 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, up to 18 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04837105 currently recruiting?

Yes, NCT04837105 is actively recruiting participants. Visit ClinicalTrials.gov or contact Fondation Ellen Poidatz to inquire about joining.

Where is the NCT04837105 trial being conducted?

This trial is being conducted at Saint-Fargeau-Ponthierry, France.

Who is sponsoring the NCT04837105 clinical trial?

NCT04837105 is sponsored by Fondation Ellen Poidatz. The trial plans to enroll 14 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology